Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial
Titel:
Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial
Auteur:
Hill, Louise F Clements, Michelle N Turner, Mark A DonĂ , Daniele Lutsar, Irja Jacqz-Aigrain, Evelyne Heath, Paul T Roilides, Emmanuel Rawcliffe, Louise Alonso-Diaz, Clara Baraldi, Eugenio Dotta, Andrea Ilmoja, Mari-Liis Mahaveer, Ajit Metsvaht, Tuuli Mitsiakos, George Papaevangelou, Vassiliki Sarafidis, Kosmas Walker, A Sarah Sharland, Michael